EYPT:EyePoint Pharmaceuticals Inc - Stock Price Quote and Dividend Data
EYPT STOCK PRICE LATEST CLOSE
$4.80
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
EyePoint Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Split Payment TypeReverse Split
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
EyePoint Pharmaceuticals Inc Stock Price Information
52-Week Low/High Stock Price$3.91 - $23.65
Percent Held by Institutions37.76%
Revenue$54,861,000
Net Income$-172,269,000
Cash Flow$-162,075,000
EPS-0.65%
Market Cap$329,899,200
PE Ratio to Industry40%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.42%
Total Return Last 12 Months-77.89%
Total Return Last 3 Years-59.83%
Total Return Last 5 Years-40.73%
Latest Trade DateApr. 10, 2025
EyePoint Pharmaceuticals Inc Annual Stock Dividends
No Data available for Payment History.
EyePoint Pharmaceuticals Inc Dividend Payment History
| No dividends retrieved for EYPT |
EyePoint Pharmaceuticals Inc Other Dividend Details
EyePoint Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. Co. is focused on the business of developing and commercializing ophthalmic products for the treatment of eye diseases. Co.'s pipeline leverages its Durasert technology (Durasert) for sustained intraocular drug delivery, including delivery of EYP-1901, is an investigational sustained delivery treatment for anti-vascular endothelial growth factor (anti-VEGF) mediated retinal diseases. Its additional pipeline programs include EYP-2301, a promising TIE-2 agonist, razuprotafib, formulated in Durasert E to potentially improve outcomes in serious retinal diseases.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Apr. 10, 2025EYPT STOCK PRICE INCREASE: EyePoint Pharmaceuticals Inc on 04-10-2025 increased stock price > 10% from $4.13 to $4.57
Apr. 09, 2025EYPT STOCK PRICE DECREASE: EyePoint Pharmaceuticals Inc on 04-09-2025 decreased stock price > 10% from $4.62 to $4.13
Feb. 07, 2025EYPT STOCK PRICE DECREASE: EyePoint Pharmaceuticals Inc on 02-07-2025 decreased stock price > 10% from $7.80 to $6.62
Jan. 23, 2025EYPT STOCK PRICE INCREASE: EyePoint Pharmaceuticals Inc on 01-23-2025 increased stock price > 10% from $7.63 to $8.72
Nov. 16, 2024EYPT STOCK PRICE DECREASE: EyePoint Pharmaceuticals Inc on 11-16-2024 decreased stock price > 10% from $10.49 to $9.17
Oct. 29, 2024EYPT STOCK PRICE INCREASE: EyePoint Pharmaceuticals Inc on 10-29-2024 increased stock price > 10% from $9.50 to $12.12
Oct. 17, 2024EYPT STOCK PRICE INCREASE: EyePoint Pharmaceuticals Inc on 10-17-2024 increased stock price > 10% from $9.88 to $11.28
Oct. 15, 2024EYPT STOCK PRICE INCREASE: EyePoint Pharmaceuticals Inc on 10-15-2024 increased stock price > 10% from $8.83 to $10.17
Aug. 22, 2024EYPT STOCK PRICE INCREASE: EyePoint Pharmaceuticals Inc on 08-22-2024 increased stock price > 10% from $7.72 to $9.05
Jul. 12, 2024EYPT STOCK PRICE INCREASE: EyePoint Pharmaceuticals Inc on 07-12-2024 increased stock price > 10% from $8.69 to $9.91
Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00
Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66
Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08
Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06
Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94
Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20
Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12
Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83
Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13
